Literature DB >> 27925198

Cancer Cell Plasticity: Rapid Reversal of Chemosensitivity and Expression of Stemness Markers in Lung and Breast Cancer Tumorspheres.

Juan Sebastian Yakisich1, Neelam Azad1, Vivek Kaushik1, Anand Krishnan V Iyer1.   

Abstract

In cancer cells, the reversible nature of the stemness status in terms of chemoresistance has been poorly characterized. In this study, we have simulated one cycle of environmental conditions to study such reversibility by first generating floating tumorspheres (FTs) from lung and breast cancer cells by culturing them in serum-free media without the addition of any external mitogenic stimulation, and subsequently (after 2 weeks) re-incubating them back in serum-containing media to simulate routine culture conditions (RCCs). We found that cancer cells are extremely plastic: cells grown under RCCs become multidrug-resistant when grown as FTs, but upon re-incubation under RCCs quickly re-attach and lose the acquired resistance. These phenotypic changes are accompanied by concomitant changes in the expression of key proteins associated with multiple pathways important for chemoresistance, survival, and stemness maintenance. Therefore, our strategy provides an excellent experimental model to study environmental factors that modulate the plasticity of cancer cells. J. Cell. Physiol. 232: 2280-2286, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27925198      PMCID: PMC5444977          DOI: 10.1002/jcp.25725

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  47 in total

Review 1.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization.

Authors:  Virginia Tirino; Vincenzo Desiderio; Francesca Paino; Alfredo De Rosa; Federica Papaccio; Marcella La Noce; Luigi Laino; Francesco De Francesco; Gianpaolo Papaccio
Journal:  FASEB J       Date:  2012-09-28       Impact factor: 5.191

2.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells.

Authors:  Erika Pastrana; Violeta Silva-Vargas; Fiona Doetsch
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

Review 3.  Determining mammosphere-forming potential: application of the limiting dilution analysis.

Authors:  Lauren M Rota; Deborah A Lazzarino; Amber N Ziegler; Derek LeRoith; Teresa L Wood
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-06-08       Impact factor: 2.673

4.  Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.

Authors:  Fang Yang; Yina Gao; Jingshu Geng; Di Qu; Qiuyue Han; Jiping Qi; Gongyan Chen
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

5.  Chemoresistance of Lung and Breast Cancer Cells Growing Under Prolonged Periods of Serum Starvation.

Authors:  Juan Sebastian Yakisich; Rajkumar Venkatadri; Neelam Azad; Anand Krishnan V Iyer
Journal:  J Cell Physiol       Date:  2017-02-28       Impact factor: 6.384

6.  Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Authors:  Michael J Lee; Albert S Ye; Alexandra K Gardino; Anne Margriet Heijink; Peter K Sorger; Gavin MacBeath; Michael B Yaffe
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

7.  Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.

Authors:  Nino Porakishvili; Ketki Vispute; Andrew J Steele; Nadeeka Rajakaruna; Nina Kulikova; Tamar Tsertsvadze; Amit Nathwani; Rajendra N Damle; Edward A Clark; Kanti R Rai; Nicholas Chiorazzi; Peter M Lydyard
Journal:  Mol Med       Date:  2015-01-14       Impact factor: 6.354

8.  Metabolic rewiring drives resistance to targeted cancer therapy.

Authors:  Jason W Locasale
Journal:  Mol Syst Biol       Date:  2012-07-17       Impact factor: 11.429

9.  Isolation, cultivation and identification of human lung adenocarcinoma stem cells.

Authors:  DE-Geng Zhang; Ai-Gui Jiang; Hui-Yu Lu; Li-Xin Zhang; Xiao-Yan Gao
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

Review 10.  Metabolic rewiring in melanoma.

Authors:  B I Ratnikov; D A Scott; A L Osterman; J W Smith; Z A Ronai
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

View more
  5 in total

1.  Selective and Irreversible Induction of Necroptotic Cell Death in Lung Tumorspheres by Short-Term Exposure to Verapamil in Combination with Sorafenib.

Authors:  Juan Sebastian Yakisich; Yogesh Kulkarni; Neelam Azad; Anand Krishnan V Iyer
Journal:  Stem Cells Int       Date:  2017-10-19       Impact factor: 5.443

2.  Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers.

Authors:  Vivek Kaushik; Neelam Azad; Juan Sebastian Yakisich; Anand Krishnan V Iyer
Journal:  Cell Death Discov       Date:  2017-02-27

3.  The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells.

Authors:  Juan Sebastian Yakisich; Neelam Azad; Vivek Kaushik; Anand K V Iyer
Journal:  Stem Cells Int       Date:  2019-02-21       Impact factor: 5.443

4.  CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.

Authors:  Sara Bruschini; Simona di Martino; Maria Elena Pisanu; Luigi Fattore; Claudia De Vitis; Valentina Laquintana; Simonetta Buglioni; Eugenio Tabbì; Andrea Cerri; Paolo Visca; Gabriele Alessandrini; Francesco Facciolo; Christian Napoli; Marcella Trombetta; Antonio Santoro; Anna Crescenzi; Gennaro Ciliberto; Rita Mancini
Journal:  J Cell Physiol       Date:  2019-08-09       Impact factor: 6.384

Review 5.  Emerging role of lipid metabolism alterations in Cancer stem cells.

Authors:  Mei Yi; Junjun Li; Shengnan Chen; Jing Cai; Yuanyuan Ban; Qian Peng; Ying Zhou; Zhaoyang Zeng; Shuping Peng; Xiaoling Li; Wei Xiong; Guiyuan Li; Bo Xiang
Journal:  J Exp Clin Cancer Res       Date:  2018-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.